Firmonertinib (mesylate), CAS [[2130958-55-1]]

Produktübersicht

• Artikelname: Firmonertinib (mesylate), CAS [[2130958-55-1]]
• Artikelnummer: MCE-HY-112870A
• Hersteller Artikelnummer: HY-112870A
• Alternativnummer: MCE-HY-112870A-500MG,MCE-HY-112870A-10MG,MCE-HY-112870A-1G,MCE-HY-112870A-100MG,MCE-HY-112870A-50MG,MCE-HY-112870A-25MG,MCE-HY-112870A-10MMX1ML,MCE-HY-112870A-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Alflutinib (mesylate), Furmonertinib (mesylate), AST2818 (mesylate)

Produktbeschreibung

Firmonertinib (Alflutinib, Furmonertinib) mesylate is is an orally active, mutant-selective, and blood-brain barrier penetrant EGFR inhibitor. Firmonertinib mesylate inhibits EGFR active mutations as well as the T790M acquired resistant mutation. Firmonertinib mesylate has the potential for the research of cancer diseases, especially advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins mutation[1].

Produkteigenschaften

• Molekulargewicht: 664.70
• Reinheit: 99.97
• CAS Nummer: [2130958-55-1]
• Formel: C29H35F3N8O5S
• Target-Kategorie: EGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound